TY - JOUR T1 - Tranexamic acid for severe bleeding gastric antral vascular ectasia in cirrhosis JF - Gut JO - Gut SP - 750 LP - 752 DO - 10.1136/gut.42.5.750 VL - 42 IS - 5 AU - P A McCormick AU - H Ooi AU - O Crosbie Y1 - 1998/05/01 UR - http://gut.bmj.com/content/42/5/750.abstract N2 - Background—It is believed that severe portal hypertensive gastropathy probably accounts for most non-variceal bleeding episodes in patients with cirrhosis. Gastric antral vascular ectasia (GAVE) also occurs in these patients. It is not clear whether it is a variant of portal hypertensive gastropathy or a distinct condition. Patient—A patient, a 66 year od woman, with cirrhosis initially diagnosed as having portal hypertensive gastropathy and subsequently classified as GAVE is described. She required transfusion with a total of 130 units of packed red cells for gastrointestinal blood loss. Results—The bleeding did not respond to portal decompression with TIPS or beta blockers. Following treatment with oral tranexamic acid she has not required further blood transfusion over a period of 30 months. Conclusion—Tranexamic acid may be a useful treatment for refractory bleeding due to gastric antral vascular ectasia in patients with cirrhosis. ER -